Are gastrointestinal symptoms related to diabetes mellitus and glycemic control?

European Journal of Gastroenterology and Hepatology

Volumn 20, Issue 9, 2008, Pages 822-825

  Koch, Christian A ^a   Uwaifo, Gabriel I ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Depression; Gastrointestinal symptoms; Gastroparesis; Glycemic control; Irritable bowel syndrome; Type 2 diabetes

Indexed keywords

AMYLIN; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; EXENDIN 4; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; LIRAGLUTIDE; METFORMIN; PRAMLINTIDE;

ABDOMINAL PAIN; ABSORPTION; ACADEMIC ACHIEVEMENT; ALCOHOLISM; ALGORITHM; ANXIETY; APPETITE DISORDER; ARTICLE; AUTONOMIC NEUROPATHY; BEHAVIOR MODIFICATION; BLOATING; BODY MASS; CALORIE; CARDIOVASCULAR DISEASE; CHINESE; COMORBIDITY; CONSTIPATION; CUSHINGOID SYNDROME; DEPRESSION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIARRHEA; DISEASE ASSOCIATION; DYSPEPSIA; ELECTROSTIMULATION; EPIGASTRIC FULLNESS; ETHNIC GROUP; FINLAND; FIRST PASS EFFECT; FOOD INTAKE; FOOD PREFERENCE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT SCINTISCANNING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH PROMOTION; HEARTBURN; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ANXIETY AND DEPRESSION SCALE; HOSPITALIZATION; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN CLEARANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTESTINE; IRRITABLE COLON; LENGTH OF STAY; LIFESTYLE MODIFICATION; LIVER TOXICITY; LOW FAT DIET; MORBID OBESITY; NAUSEA; NEUROPATHY; NEUROSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERNUTRITION; PANDEMIC; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; POSTPRANDIAL STATE; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; SCREENING; SEX DIFFERENCE; STOMACH EMPTYING; STOMACH PARESIS; ULCER; UPPER GASTROINTESTINAL TRACT; VAGUS NERVE DISEASE; VOMITING; WEIGHT REDUCTION; BLOOD; GASTROINTESTINAL DISEASE; METABOLISM; NOTE;

BLOOD GLUCOSE; DIABETES COMPLICATIONS; GASTROINTESTINAL DISEASES; GASTROPARESIS; HUMANS; HYPERGLYCEMIA;

EID: 58149296283     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3282f5f75e     Document Type: Article

References (28)

1. Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15000 adults. Arch Intern Med 2001; 161:1989-1996.
2. Maleki D, Locke GR III, Camilleri M, Zinsmeister AR, Yawn BP, Leibson C, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000; 160:2808-2816.
3. Ko GT, Chan WB, Chan JC, Tsang LW, Cockram CS. Gastrointestinal symptoms in Chinese patients with type 2 diabetes mellitus. Diabet Med 1999; 16:670-674.
4. Enck P, Rathmann W, Spiekermann M, Czerner D, Tschoepe D, Ziegler D, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol 1994; 32:637-641.
5. Janatuinen E, Pikkarainen P, Laakso M, Pyörälä K. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 1993; 28:427-437.
6. 1This would underestimate the true burden from diabetes. Although people may live for years with diabetes, their underlying cause of death is usually recorded as heart disease or kidney failure. An alternative estimate, taking into account deaths in which diabetes was a contributory condition, suggests that approximately 2.9 million deaths per year are attributable to diabetes.
7. Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345:790-797.
8. National Center for Chronic Disease Prevention and Health. http:// www.cdc.gov/diabetes/faq/research.htm#1.
9. Trust for America Health Report http://www.ncsl.org/programs/health/ diabetes.htm, http://www.ncsl.org/programs/health/obestatres.htm, http://www.ncsl.org/programs/health/ChildhoodObesity-2006.htm, http://healthyamericans.org/reports/obesity2007/
10. Ford ES, Li C, Zhao G, Pearson WS, Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care 2008; 31:587-589.
11. Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry 2007; 29:147-155.
12. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007; 370:851-859.
13. Li C, Ford ES, Strine TW, Mokdad AH. Prevalence of depression among U.S. adults with diabetes: findings from the 2006 Behavioral Risk Factor Surveillance System. Diabetes Care 2008; 31:105-107.
14. Bogner HR, Morales KH, Post EP, Bruce ML. Diabetes, depression, and death: a randomized, controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care 2007; 30:3005-3010.
15. Talley SJ, Bytzer P, Hammer J, Young L, Jones M, Horowitz M. Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001; 96:1033-1038.
16. Quan C, Talley NJ, Jones MP, Howell S, Horowitz M. Gastrointestinal symptoms and glycemic control in diabetes mellitus: a longitudinal population study. Eur J Gastroenterol Hepatol 2008; 20:888-897.
17. Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. Corticotropin- releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudoCushing's states. J Am Med Assoc 1993; 269:2232-2238.
18. Koch CA, Chrousos GP. Cushing's disease. In: Powell MP, Lightman SL, Laws ER Jr, editors. Management of pituitary tumors. The clinician's practical guide. 2nd ed. Totowa, NJ: Humana Press, Inc.; 2003. pp. 51-75.
19. Horowitz M, O'Donovan D, Jones KL, Feinle C, Rayner CK, Sampson M. Gastric emptying in diabetes: clinical significance and treatment. Diabet Med 2002; 19:177-194.
20. Revicki DA, Rentz AM, Dubois D, Kahrilas P, Stanghellini V, Talley NJ, Tack J. Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18:141-150.
21. Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: trends, characteristics, and outcomes, 1995-2004. Am J Gastroenterol 2008; 103:313-322.
22. Abid S, Rizvi A, Jahan F, Rabbani F, Islam N, Khan MH, et al. Poor glycemic control is the major factor associated with increased frequency of gastrointestinal symptoms in patients with diabetes mellitus. J Pak Med Assoc 2007; 57:345-349.
23. Camilleri M. Functional dyspepsia: mechanisms of symptom generation and appropriate management of patients. Gastroenterol Clin North Am 2007; 36:649-664.
24. Abell T, McCallum R, Hocking M, Koch K, Abrahamsson H, Leblanc I, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 2003; 125:421-428.
25. Lin Z, Sarosiek I, Forster J, McCallum RW. Symptom responses, long-term outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol Motil 2006; 18:18-27.
26. Abell T, Camilleri M, Donohoe K, Hasler WL, Lin HC, Maurer AH, et al. Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol 2008; 103:753-763.
27. Yan L. Diabulimia: a growing problem among diabetic girls. Nephrol News Issues 2007; 21:36-38.
28. Meneghini LF, Spadola J, Florez H. Prevalence and associations of binge eating disorder in a multiethnic population with type 2 diabetes. Diabetes Care 2006; 12:2760.